Is ERCP-BD or EUS-BD the preferred decompression modality for malignant distal biliary obstruction? A meta-analysis of randomized controlled trials | Zendy

Defeng Li | Zendy; Chunhua Zhou | Zendy; LiSheng Wang | Zendy; Jun Yao | Zendy; Duowu Zou | Zendy

Open Access

Is ERCP-BD or EUS-BD the preferred decompression modality for malignant distal biliary obstruction? A meta-analysis of randomized controlled trials

Author(s) -

Defeng Li,

Chunhua Zhou,

LiSheng Wang,

Jun Yao,

Duowu Zou

Publication year - 2019

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.331

H-Index - 38

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2019.6125/2018

Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , endoscopic ultrasound , adverse effect , confidence interval , randomized controlled trial , stent , cochrane library , radiology , gastroenterology , surgery , pancreatitis

endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary drainage (ERCP-BD) with transpapillary stent placement is the standard palliative treatment for malignant distal biliary obstruction. Endoscopic ultrasound-guided biliary drainage (EUS-BD) has been evaluated for efficacy and safety as an alternative for failed ERCP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research